MesotheliomaDR logo

24/7 Patient Assistance: 760-405-8205

Eyal Meiri, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Bio & Insurance Information

    Dr. Eyal Meiri is a medical oncologist from Newnan, Georgia. He got his diploma from University of Toronto Faculty of Medicine, and he is certified in Internal Medicine, Medical Oncology.

  • Education & Training

    dept_icon

    University of Toronto Faculty of Medicine

    Medical School

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Eyal Meiri has contributed to 2 publications.

    A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.

    Maison-Blanche P Vermorken JB Goksel T Machiels JP Agarwala S Rottey S Daugaard G Volovat C Scheulen M Sengelov L Grecea D Eniu A Jager E Meiri E Cascinu S Strumberg D...; J Cardiovasc Pharmacol. 2013 Jun .

    See more >>

    Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.

    Meiri E Jhangiani H Vredenburgh JJ Barbato LM Carter FJ Yang HM Baranowski V; Curr Med Res Opin. 2007 Mar .

    See more >>